# Intramuscular Peramivir for the Treatment of Uncomplicated Influenza

> **NCT00486980** · PHASE3 · WITHDRAWN · sponsor: **BioCryst Pharmaceuticals**

## Conditions studied

- Influenza

## Interventions

- **DRUG:** Peramivir 150mg
- **DRUG:** Peramivir 300mg

## Key facts

- **NCT ID:** NCT00486980
- **Lead sponsor:** BioCryst Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Why stopped:** This study was withdrawn for administrative reasons. The dose ranging plan for the program was revised".
- **Last updated:** 2008-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00486980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00486980, "Intramuscular Peramivir for the Treatment of Uncomplicated Influenza". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00486980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*